These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33287862)

  • 1. Rhenium N-heterocyclic carbene complexes block growth of aggressive cancers by inhibiting FGFR- and SRC-mediated signalling.
    Domenichini A; Casari I; Simpson PV; Desai NM; Chen L; Dustin C; Edmands JS; van der Vliet A; Mohammadi M; Massi M; Falasca M
    J Exp Clin Cancer Res; 2020 Dec; 39(1):276. PubMed ID: 33287862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the Anti-Cancer Activity of Tricarbonyl Rhenium Complexes: Induction of G2/M Cell Cycle Arrest and Blockade of Aurora-A Kinase Phosphorylation.
    Simpson PV; Casari I; Paternoster S; Skelton BW; Falasca M; Massi M
    Chemistry; 2017 May; 23(27):6518-6521. PubMed ID: 28337805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and
    Nasiri Sovari S; Kolly I; Schindler K; Djuric A; Srdic-Rajic T; Crochet A; Pavic A; Zobi F
    Dalton Trans; 2023 May; 52(20):6934-6944. PubMed ID: 36916301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment of prostate cancer with FGF receptor and AKT kinase inhibitors.
    Feng S; Shao L; Castro P; Coleman I; Nelson PS; Smith PD; Davies BR; Ittmann M
    Oncotarget; 2017 Jan; 8(4):6179-6192. PubMed ID: 28008155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
    Knopf KM; Murphy BL; MacMillan SN; Baskin JM; Barr MP; Boros E; Wilson JJ
    J Am Chem Soc; 2017 Oct; 139(40):14302-14314. PubMed ID: 28948792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma.
    Delasoie J; Pavic A; Voutier N; Vojnovic S; Crochet A; Nikodinovic-Runic J; Zobi F
    Eur J Med Chem; 2020 Oct; 204():112583. PubMed ID: 32731186
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lenis-Rojas OA; Cordeiro S; Horta-Meireles M; Fernández JAA; Fernández Vila S; Rubiolo JA; Cabezas-Sainz P; Sanchez L; Fernandes AR; Royo B
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclometalated Palladium(II) N-Heterocyclic Carbene Complexes: Anticancer Agents for Potent In Vitro Cytotoxicity and In Vivo Tumor Growth Suppression.
    Fong TT; Lok CN; Chung CY; Fung YM; Chow PK; Wan PK; Che CM
    Angew Chem Int Ed Engl; 2016 Sep; 55(39):11935-9. PubMed ID: 27571430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iridium(III) carbene complexes as potent girdin inhibitors against metastatic cancers.
    Ruan ML; Ni WX; Chu JCH; Lam TL; Law KC; Zhang Y; Yang G; He Y; Zhang C; Fung YME; Liu T; Huang T; Lok CN; Chan SL; Che CM
    Proc Natl Acad Sci U S A; 2024 Jun; 121(25):e2316615121. PubMed ID: 38861602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dinuclear Rhenium(I) Tricarbonyl Complexes as Anticancer Drug Candidates.
    Montesdeoca N; Borkar RL; Sathiyendiran M; Karges J
    Chemistry; 2024 Jun; 30(32):e202400217. PubMed ID: 38574234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.
    Collery P; Veena V; Harikrishnan A; Desmaele D
    Invest New Drugs; 2019 Oct; 37(5):973-983. PubMed ID: 30632005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of Rhenium Compounds in Targeted Anticancer Therapeutics.
    Collery P; Desmaele D; Vijaykumar V
    Curr Pharm Des; 2019; 25(31):3306-3322. PubMed ID: 31475892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial Synthesis to Identify a Potent, Necrosis-Inducing Rhenium Anticancer Agent.
    Konkankit CC; Vaughn BA; MacMillan SN; Boros E; Wilson JJ
    Inorg Chem; 2019 Mar; 58(6):3895-3909. PubMed ID: 30793900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Heterocyclic carbene metal complexes in medicinal chemistry.
    Oehninger L; Rubbiani R; Ott I
    Dalton Trans; 2013 Mar; 42(10):3269-84. PubMed ID: 23223752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preclinical evaluation of SKLB261, a multikinase inhibitor of EGFR/Src/VEGFR2, as a therapeutic agent against pancreatic cancer.
    Pan Y; Zheng M; Zhong L; Yang J; Zhou S; Qin Y; Xiang R; Chen Y; Yang SY
    Mol Cancer Ther; 2015 Feb; 14(2):407-18. PubMed ID: 25519702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.